LADX
Price
$1.65
Change
+$0.15 (+10.00%)
Updated
Jul 11 closing price
Capitalization
816.9K
NICXF
Price
$0.25
Change
-$0.03 (-10.71%)
Updated
Mar 24 closing price
Capitalization
19.1M
Interact to see
Advertisement

LADX vs NICXF

Header iconLADX vs NICXF Comparison
Open Charts LADX vs NICXFBanner chart's image
LadRx
Price$1.65
Change+$0.15 (+10.00%)
Volume$319
Capitalization816.9K
Nicox S.A
Price$0.25
Change-$0.03 (-10.71%)
Volume$500
Capitalization19.1M
LADX vs NICXF Comparison Chart in %
Loading...
LADX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LADX vs. NICXF commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LADX is a Buy and NICXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (LADX: $1.65 vs. NICXF: $0.25)
Brand notoriety: LADX and NICXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LADX: 72% vs. NICXF: 100%
Market capitalization -- LADX: $762.44K vs. NICXF: $19.37M
LADX [@Biotechnology] is valued at $762.44K. NICXF’s [@Biotechnology] market capitalization is $19.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $300.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LADX’s FA Score shows that 0 FA rating(s) are green whileNICXF’s FA Score has 0 green FA rating(s).

  • LADX’s FA Score: 0 green, 5 red.
  • NICXF’s FA Score: 0 green, 5 red.
According to our system of comparison, both LADX and NICXF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LADX’s TA Score shows that 6 TA indicator(s) are bullish.

  • LADX’s TA Score: 6 bullish, 3 bearish.

Price Growth

LADX (@Biotechnology) experienced а -8.33% price change this week, while NICXF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.70%. For the same industry, the average monthly price growth was +10.20%, and the average quarterly price growth was +39.68%.

Reported Earning Dates

LADX is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+2.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NICXF($19.1M) has a higher market cap than LADX($817K). NICXF YTD gains are higher at: 4.167 vs. LADX (-1.786).
LADXNICXFLADX / NICXF
Capitalization817K19.1M4%
EBITDA-3.51MN/A-
Gain YTD-1.7864.167-43%
P/E Ratio1.88N/A-
Revenue0N/A-
Total Cash207KN/A-
Total Debt0N/A-
FUNDAMENTALS RATINGS
LADX vs NICXF: Fundamental Ratings
LADX
NICXF
OUTLOOK RATING
1..100
2833
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6062
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LADX's Valuation (50) in the Pharmaceuticals Other industry is in the same range as NICXF (50) in the null industry. This means that LADX’s stock grew similarly to NICXF’s over the last 12 months.

LADX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as NICXF (100) in the null industry. This means that LADX’s stock grew similarly to NICXF’s over the last 12 months.

LADX's SMR Rating (100) in the Pharmaceuticals Other industry is in the same range as NICXF (100) in the null industry. This means that LADX’s stock grew similarly to NICXF’s over the last 12 months.

LADX's Price Growth Rating (60) in the Pharmaceuticals Other industry is in the same range as NICXF (62) in the null industry. This means that LADX’s stock grew similarly to NICXF’s over the last 12 months.

LADX's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as NICXF (100) in the null industry. This means that LADX’s stock grew similarly to NICXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LADXNICXF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
10%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
8%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
LADX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIRD11.60-0.17
-1.44%
Allbirds Inc
DIOD55.20-0.83
-1.48%
Diodes
INAB2.16-0.05
-2.48%
IN8bio Inc
LW49.79-1.28
-2.51%
Lamb Weston Holdings
PRME4.29-0.51
-10.72%
Prime Medicine

LADX and

Correlation & Price change

A.I.dvisor tells us that LADX and TCRX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LADX and TCRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LADX
1D Price
Change %
LADX100%
N/A
TCRX - LADX
22%
Poorly correlated
-7.81%
MREO - LADX
22%
Poorly correlated
-0.58%
NXTC - LADX
21%
Poorly correlated
-2.86%
NICXF - LADX
20%
Poorly correlated
N/A
IFRX - LADX
20%
Poorly correlated
-8.74%
More

NICXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NICXF has been loosely correlated with MDXXF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if NICXF jumps, then MDXXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NICXF
1D Price
Change %
NICXF100%
N/A
MDXXF - NICXF
46%
Loosely correlated
-2.82%
CLVLF - NICXF
22%
Poorly correlated
N/A
LADX - NICXF
20%
Poorly correlated
N/A
NTRB - NICXF
19%
Poorly correlated
+0.56%
COEP - NICXF
2%
Poorly correlated
-0.61%
More